Bank of Montreal Can Has $9.03 Million Stock Position in Aehr Test Systems (NASDAQ:AEHR)

Bank of Montreal Can cut its stake in Aehr Test Systems (NASDAQ:AEHR) by 20.4% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 808,611 shares of the semiconductor company’s stock after selling 206,632 shares during the period. Bank of Montreal Can owned approximately 2.80% of Aehr Test Systems worth $9,032,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Congress Asset Management Co. MA acquired a new stake in shares of Aehr Test Systems during the 4th quarter worth approximately $23,229,000. Charles Schwab Investment Management Inc. raised its stake in shares of Aehr Test Systems by 4.5% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 209,670 shares of the semiconductor company’s stock valued at $5,563,000 after buying an additional 9,117 shares in the last quarter. General American Investors Co. Inc. bought a new position in shares of Aehr Test Systems during the 4th quarter worth about $2,640,000. Baillie Gifford & Co. boosted its position in shares of Aehr Test Systems by 25.1% during the 1st quarter. Baillie Gifford & Co. now owns 828,626 shares of the semiconductor company’s stock valued at $10,275,000 after acquiring an additional 166,319 shares in the last quarter. Finally, Greenwood Capital Associates LLC increased its stake in Aehr Test Systems by 10.6% in the fourth quarter. Greenwood Capital Associates LLC now owns 21,046 shares of the semiconductor company’s stock valued at $558,000 after acquiring an additional 2,023 shares during the period. 69.69% of the stock is currently owned by institutional investors and hedge funds.

Aehr Test Systems Stock Performance

Shares of NASDAQ:AEHR opened at $12.85 on Tuesday. The business has a fifty day moving average of $14.41 and a 200-day moving average of $13.09. Aehr Test Systems has a twelve month low of $9.83 and a twelve month high of $48.28. The firm has a market cap of $371.56 million, a PE ratio of 24.71 and a beta of 2.05.

Aehr Test Systems (NASDAQ:AEHR) last posted its quarterly earnings data on Friday, July 19th. The semiconductor company reported $0.81 earnings per share for the quarter, beating the consensus estimate of $0.11 by $0.70. Aehr Test Systems had a net margin of 50.07% and a return on equity of 36.41%. The firm had revenue of $16.60 million during the quarter. During the same quarter in the previous year, the business posted $0.21 EPS. On average, analysts anticipate that Aehr Test Systems will post 0.25 EPS for the current fiscal year.

Analyst Ratings Changes

A number of research analysts have commented on the stock. StockNews.com raised Aehr Test Systems from a “sell” rating to a “hold” rating in a report on Friday. Craig Hallum raised Aehr Test Systems from a “hold” rating to a “buy” rating and boosted their price target for the company from $12.00 to $25.00 in a research note on Wednesday, July 17th.

Insiders Place Their Bets

In other news, Director Howard T. Slayen acquired 20,000 shares of the stock in a transaction that occurred on Friday, August 2nd. The stock was purchased at an average cost of $15.50 per share, for a total transaction of $310,000.00. Following the completion of the transaction, the director now directly owns 220,714 shares in the company, valued at $3,421,067. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. In other Aehr Test Systems news, Director Howard T. Slayen acquired 20,000 shares of the business’s stock in a transaction that occurred on Friday, August 2nd. The shares were acquired at an average cost of $15.50 per share, for a total transaction of $310,000.00. Following the completion of the acquisition, the director now directly owns 220,714 shares of the company’s stock, valued at approximately $3,421,067. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Fariba Danesh sold 10,000 shares of Aehr Test Systems stock in a transaction on Tuesday, July 30th. The stock was sold at an average price of $18.59, for a total transaction of $185,900.00. Following the sale, the director now directly owns 16,390 shares of the company’s stock, valued at approximately $304,690.10. The disclosure for this sale can be found here. Company insiders own 11.30% of the company’s stock.

Aehr Test Systems Company Profile

Aehr Test Systems provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide. Its product portfolio includes FOX-XP and FOX-NP systems that are full wafer contact and singulated die/module test and burn-in systems that can test, burn-in, and stabilize range of devices, including silicon carbide-based and other power semiconductors, 2D and 3D sensors used in mobile phones, tablets and other computing devices, memory semiconductors, processors, microcontrollers, systems-on-a-chip, and photonics and integrated optical devices.